Business Context and Reporting Period
This Form 8-K is filed by Fluidigm Corporation (not Standard BioTools Inc.) on January 14, 2014. The report discloses the issuance of a press release containing preliminary fourth quarter 2013 revenue results and 2014 revenue guidance.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) for these details, but the content of that exhibit is not included in the provided text.
Material Changes
No specific material changes or comparative financial data are detailed within the body of this filing. The document serves solely to announce the availability of preliminary Q4 2013 results and 2014 guidance.
Guidance, Outlook, and Risks
- Guidance: The company issued 2014 revenue guidance, though specific figures are not stated in this text.
- Outlook: Preliminary fourth quarter 2013 revenue was announced.
- Risks and Contingencies: The filing includes a standard disclaimer stating that the information furnished under Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference, except as expressly set forth by specific reference.
Investor Verification Checklist
- Verify the specific preliminary Q4 2013 revenue figure in the attached press release (Exhibit 99.1).
- Confirm the exact 2014 revenue guidance range provided in the press release.
- Review the full press release for any qualitative commentary on market conditions or operational challenges not captured in this summary.
- Note the discrepancy between the request metadata (Standard BioTools Inc.) and the actual registrant (Fluidigm Corporation).